Welcome to Peak LiLT, Neuro!
We have been steadily shifting our focus to utilize the science of Photobiomodulation to help people suffering from neurological conditions and neurodegenerative diseases, with many exciting and promising results.
There is a growing body of evidence that supports the effectiveness of transcranial Photobiomodulation for the treatment of the following conditions:
- Traumatic Brain Injury and Concussions: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10931349 , including CTE in retired football players: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912826/#:~:text=Delivering%20NIR%20photons%20to%20both%20the%20mPFC
- Stroke Recovery: “Further, in patients suffering from either chronic stroke or Alzheimer’s disease, both of which have abnormally functioning networks, light can strengthen and influence functional connectivities within the default mode network itself, together with its connectivity with other networks, for example the salience and central executive ones. In essence, in these damaged and/or diseased states, light may help correct the imbalance of functional connectivity, restoring the connectivity between cortical regions to “normal” levels (Saltmarche et al., 2017; Chao, 2019; Zomorrodi et al., 2019; Naeser et al., 2020).”
- Parkinson’s Disease: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10819946/
- Alzheimer’s Disease: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369090/
- https://youtu.be/MMrCdy-tG6E?si=Cu4OSU0Z8Km4QN03
- ALS: Photobiomodulation for Neurodegenerative Diseases: A Scoping Review – PMC (nih.gov)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10855709/
- Autism Spectrum Disorder: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680350/
- Anxiety and Depression: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878920/
- Autonomic Nervous System Dysfunction: Healthy Autonomic Nervous System regulation is extremely important for our overall health and functioning. It is common for the ANS to become dysregulated, and this can lead to a variety of disease processes and conditions (click on the link to learn more about ANS Dysfunction and how we are treating this with PBM):
- Fatigue
- Headaches, including Migraines
- Brain Fog, Forgetfulness, Difficulty Concentrating
- Anxiety and Depression
- Sleep Disorder
- Dizziness
- Digestive Issues such as Constipation, IBS, GERD, Ulcerative Colitis, Chrone’s, and SIBO
- Cardiovascular Disease, including blood clots and stroke
- High Blood Pressure
- Respiratory Diseases, including Asthma
- Allergies
- Inflammatory conditions such as Psoriatic Arthritis and Eczema
- And even Osteoporosis, secondary to the large role the Autonomic Nervous System plays in healthy bone remodeling. If we are “stuck in Fight or Flight”, then an over-active sympathetic nervous system reduces production of healthy bone and also reduces the removal of old bone: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088147/figure/F0005/
How Does Photobiomodulation work in the brain?
The mechanisms of action behind transcranial Photobiomodulation (tPBM) in the brain are numerous:
- Enhanced cerebral blood flow
- Angiogenesis (the formation of new capillary beds)
- Anti-neuroinflammation
- Reduction of neuronal cell death
- Neurogenesis (the formation of new brain cells)
- Neurosynapsis (the formation of new neuronal networks)
- Increase in Neurotropic Factors such as BDNF
- Enhanced Mitochondrial Functioning
- Reduction in Amyloid plaque burden
In conclusion, the field of Photobiomodulation is rapidly growing, with a burgeoning body of research, including numerous Clinical Controlled Trials, which substantiate its safety and efficacy in treating a variety of Neurological Conditions:
Photobiomodulation for Sports Concussion Injury and TBI: Research at the University of Utah:
Dementia and Brain Photobiomodulation Research Video by Vie Light:
Shining a Light on Cognitive Health: Interview with Dr. Paolo Cassano, MD, head of Photobiomodulation Research Center at Boston Mass General Hospital
Dr. Michael Hamblin Explains the Mechanisms Behind Photobiomodulation in the Brain:
Interview with Catherine Hamilton, MD: Photobiomodulation for Parkinson’s Disease:
